DE602005009110D1 - Injektierbare wässrige Paclitaxel-Lösungen und Verfahren zu ihrer Herstellung - Google Patents
Injektierbare wässrige Paclitaxel-Lösungen und Verfahren zu ihrer HerstellungInfo
- Publication number
- DE602005009110D1 DE602005009110D1 DE602005009110T DE602005009110T DE602005009110D1 DE 602005009110 D1 DE602005009110 D1 DE 602005009110D1 DE 602005009110 T DE602005009110 T DE 602005009110T DE 602005009110 T DE602005009110 T DE 602005009110T DE 602005009110 D1 DE602005009110 D1 DE 602005009110D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical composition
- preparation
- injectable aqueous
- injectable pharmaceutical
- paclitaxel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 4
- 229960001592 paclitaxel Drugs 0.000 title abstract 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/995,262 US7361683B2 (en) | 2004-11-24 | 2004-11-24 | Paclitaxel aqueous injection solution and methods for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005009110D1 true DE602005009110D1 (de) | 2008-10-02 |
Family
ID=34933891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005009110T Expired - Lifetime DE602005009110D1 (de) | 2004-11-24 | 2005-02-23 | Injektierbare wässrige Paclitaxel-Lösungen und Verfahren zu ihrer Herstellung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7361683B2 (de) |
| EP (1) | EP1666069B1 (de) |
| JP (1) | JP4805599B2 (de) |
| AT (1) | ATE405292T1 (de) |
| DE (1) | DE602005009110D1 (de) |
| TW (1) | TWI303566B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2047857T1 (sl) * | 2006-06-29 | 2012-03-30 | Arigen Pharmaceuticals Inc | Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo |
| GB2445746A (en) * | 2007-01-17 | 2008-07-23 | Texcontor Ets | Use of carbonated water as a solvent for freeze drying, and method of purification comprising dissolution of material in carbonated water and freeze drying |
| DE102007021862A1 (de) * | 2007-05-10 | 2008-11-13 | Merck Patent Gmbh | Wässrige pharmazeutische Zubereitung |
| CN101396354B (zh) * | 2007-09-30 | 2010-12-01 | 江苏恒瑞医药股份有限公司 | 一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用 |
| EP2829273B1 (de) * | 2012-03-22 | 2018-08-29 | Ensuiko Sugar Refining Co., Ltd. | Verfahren zur herstellung von liposomen zur verkapselung von paclitaxel-monoglycosid und/oder docetaxel-monoglycosid |
| WO2014028704A1 (en) * | 2012-08-15 | 2014-02-20 | Yung Shin Pharm. Ind. Co., Ltd. | Stable pharmaceutical formulation of cabazitaxel |
| TW201420130A (zh) * | 2012-09-26 | 2014-06-01 | Neochemir Inc | 溶解有二氧化碳之液狀藥劑及其投藥方法 |
| EP3092027A4 (de) * | 2014-01-10 | 2017-09-06 | Atossa Genetics Inc. | Transpapilläre verfahren und zusammensetzungen zur diagnose und behandlung von brusterkrankungen |
| CN119139479A (zh) | 2015-09-16 | 2024-12-17 | Dfb索里亚有限责任公司 | 包含紫杉烷类纳米颗粒的组合物及其用途 |
| EP3595633B1 (de) | 2017-03-15 | 2023-07-05 | DFB Soria, LLC | Topische therapie zur behandlung von hautmalignitäten mit taxan nanopartikeln |
| CN112165949A (zh) | 2018-03-16 | 2021-01-01 | Dfb索里亚有限责任公司 | 使用紫杉烷纳米颗粒治疗宫颈上皮内瘤变(cin)和宫颈癌的局部疗法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0835657B1 (de) | 1992-11-27 | 2004-08-25 | Mayne Pharma (USA) Inc. | Stabile injizierbare Paclitaxel Lösung |
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| JP4000426B2 (ja) * | 1996-05-08 | 2007-10-31 | 株式会社大塚製薬工場 | 輸液製剤 |
| JP3375518B2 (ja) * | 1997-06-23 | 2003-02-10 | 清水製薬株式会社 | 注射剤 |
| JP2003201242A (ja) * | 2001-12-28 | 2003-07-18 | Shimizu Pharmaceutical Co Ltd | 重曹リンゲル様液剤 |
-
2004
- 2004-11-24 US US10/995,262 patent/US7361683B2/en not_active Expired - Fee Related
-
2005
- 2005-02-23 AT AT05003915T patent/ATE405292T1/de not_active IP Right Cessation
- 2005-02-23 EP EP05003915A patent/EP1666069B1/de not_active Expired - Lifetime
- 2005-02-23 DE DE602005009110T patent/DE602005009110D1/de not_active Expired - Lifetime
- 2005-04-15 JP JP2005118226A patent/JP4805599B2/ja not_active Expired - Fee Related
- 2005-06-02 TW TW094118128A patent/TWI303566B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7361683B2 (en) | 2008-04-22 |
| TWI303566B (en) | 2008-12-01 |
| EP1666069A1 (de) | 2006-06-07 |
| US20060111432A1 (en) | 2006-05-25 |
| JP4805599B2 (ja) | 2011-11-02 |
| TW200616616A (en) | 2006-06-01 |
| JP2006143699A (ja) | 2006-06-08 |
| EP1666069B1 (de) | 2008-08-20 |
| ATE405292T1 (de) | 2008-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0508540A8 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| ATE473976T1 (de) | Dipeptidylpeptidase-iv-inhibierende verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| ATE555777T1 (de) | Pharmazeutische zusammensetzung | |
| JP2005343897A5 (de) | ||
| DE602005009110D1 (de) | Injektierbare wässrige Paclitaxel-Lösungen und Verfahren zu ihrer Herstellung | |
| CY1110316T1 (el) | Χρηση πιπαμπερονης και ενος sndri, snri ή ssri για την θεραπεια διαταραχων ψυχικης διαθεσης ή αγχους | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| HRP20140215T1 (hr) | Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika | |
| BRPI0414777A (pt) | compostos, composições farmacêuticas, uso de um ou mais compostos, e, método de tratar um paciente que sofre de um distúrbio | |
| BRPI0407529A (pt) | uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática | |
| WO2006071564A3 (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
| ATE376834T1 (de) | Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase | |
| ATE430126T1 (de) | Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen | |
| ATE513841T1 (de) | Neue thioxyloseverbindungen, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren verwendung in therapeutika | |
| JP4819587B2 (ja) | アスコルビン酸のグリセリン溶液の製造方法及びアスコルビン酸のグリセリン溶液並びにアスコルビン酸のグリセリン溶液からなる化粧料素材。 | |
| EP1852119A4 (de) | Pharmazeutische zusammensetzung mit einer phenoxazinium-verbindung als wirkstoff | |
| EA200701741A1 (ru) | Композиция, содержащая окаперидон | |
| ATE406173T1 (de) | Stabile zubereitung enthaltend eine kombination aus einer feuchtigkeitsempfindlichen aktiven substanz und einer zweiten aktiven substanz und verfahren zur herstellung der zubereitung. | |
| TH89989A (th) | อนุพันธ์ฆ่ารา n-ไซโคลแอลคิล-เบนซิล-แอมีด | |
| ATE396732T1 (de) | Neue antivirale pharmazeutische zusammensetzung | |
| TH83066A (th) | สารประกอบเคมี | |
| TH84975A (th) | อนุพันธ์ไซยาโนไพริดีนชนิดใหม่ที่มีประโยชน์ในการบำบัดมะเร็งและความผิดปกติอื่นๆ | |
| AR040184A1 (es) | Composiciones farmaceuticas estabilizadas basadas en aceite de ricino polioxietilado y metodo para la fabricacion de las mismas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |